Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Net Cash Flow - Operations | Operating Cash Flow per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -55.77M | $ -7.11 | 1 | 7.84M |
3/31/2025 | $ -66.36M | $ -13.73 | 1 | 4.83M |
12/31/2024 | $ -72.03M | $ -28.41 | 1 | 2.54M |
9/30/2024 | $ -84.08M | $ -31.74 | 1 | 2.65M |
6/30/2024 | $ -105.33M | $ -41.87 | 1 | 2.52M |
3/31/2024 | $ -120.36M | $ -62.39 | 1 | 1.93M |
12/31/2023 | $ -155.01M | $ -85.14 | 1 | 1.82M |
9/30/2023 | $ -166.78M | $ -91.18 | 1 | 1.83M |
6/30/2023 | $ -160.38M | $ -87.92 | 1 | 1.82M |
3/31/2023 | $ -155.28M | $ -86.82 | 1 | 1.79M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Operations / (Shares WA * Share Factor)
(=) OCFPS
OCFPS for BIOXCEL THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -54M ] / (Shares WA [ 1.44M ] * Share Factor [ 1 ])
(=) OCFPS [ $ -37.48 ]
Minimum
Sep 30, 2023
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.78K |
---|---|
min | $ -9.04 |
max | $ 11.43 |
average | $ 1.66 |
median | $ 0.9 |
std | $ 3.42 |